Schedule 13G ownership disclosure
Coherus Oncology Inc
Security class unavailable · CUSIP: 19249H103
Event date: 2023-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-062515
- Form type
- SC 13G
- Filer
- CITADEL ADVISORS LLC
- CIK
- CIK 1423053
- Filed
- May 19, 2023
- Reporting period
- May 18, 2023
- Description
- Schedule 13G beneficial ownership